Genomics Gets Personal
Despite Data and Privacy Challenges, Decreasing Cost Ushers in the Age of Personalized Whole-Genome Sequencing
GEN Roundup: Modular Proofs of Flexible Bioprocessing
In Combination, Prefab Unit Operations Can Accommodate Diverse Product Lines and Meet Shifting Capacity Demands
With Digital PCR, the Rare Becomes Routine
Applications Which Bring Rare Events to Light Are Proliferating
Beyond Short Reads
Up-and-Coming Genomics Technologies Reveal Previously Unseen Structural Variants
Kevin Davies Ph.D.
Kevin Davies is Executive Vice President, Strategic Development for Mary Ann Liebert, Inc.
More GEN Content From This Contributor
- GEN News Highlights: At CRISPRcon, Debating the Promise and Perils of Gene Editing
- GEN News Highlights: Electrifying Catalysis: IKA Takes Bite Out of Apple to Launch Electrochemistry Product
- GEN News Highlights: Ring in the New: Rady Children’s Hospital Introduces NovaSeq for Newborn Diagnoses
- GEN News Highlights: Illumina’s Jay Flatley: In “Shock and Awe” at State of Personalized Medicine
- Feature Articles: Supplement: Best of CRISPR 2017
- GEN News Highlights: Illumina’s Push to Democratize Genomics with the iSeq 100
- Columns: The Scoop: How Well Are You, Really? Ask the Cloud!
- GEN Exclusives: "Unite to Cure"
- Feature Articles: Supplement: CRISPR